These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 6124876
1. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole. Laduron PM, Janssen PF, Gommeren W, Leysen JE. Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876 [Abstract] [Full Text] [Related]
2. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors]. Leysen JE, Gommeren W, Janssen PF, Sanz G, Gillardin JM, Schotte A, Janssen PA. Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249 [Abstract] [Full Text] [Related]
3. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM. Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558 [Abstract] [Full Text] [Related]
4. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. Benavides J, Schoemaker H, Dana C, Claustre Y, Delahaye M, Prouteau M, Manoury P, Allen J, Scatton B, Langer SZ. Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054 [Abstract] [Full Text] [Related]
12. N-ethylmaleimide-induced changes in agonist affinity for histamine H1-receptors in the guinea pig brain. Yeramian E, Garbarg M, Schwartz JC. Mol Pharmacol; 1985 Aug; 28(2):155-62. PubMed ID: 4022000 [Abstract] [Full Text] [Related]
13. Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study. Ter Laak AM, Donné-Op den Kelder GM, Bast A, Timmerman H. Eur J Pharmacol; 1993 Mar 02; 232(2-3):199-205. PubMed ID: 8096817 [Abstract] [Full Text] [Related]
14. Characterization of histamine H1 binding sites on human T lymphocytes by means of 125I-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes. Villemain FM, Bach JF, Chatenoud LM. J Immunol; 1990 Feb 15; 144(4):1449-54. PubMed ID: 1968079 [Abstract] [Full Text] [Related]
15. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative. Fukuda S, Midoro K, Yamasaki M, Gyoten M, Kawano Y, Fukui H, Ashida Y, Nagaya H. Inflamm Res; 2003 May 15; 52(5):206-14. PubMed ID: 12813625 [Abstract] [Full Text] [Related]
16. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor. Wallace RM, Young JM. Mol Pharmacol; 1983 Jan 15; 23(1):60-6. PubMed ID: 6135145 [Abstract] [Full Text] [Related]
19. Does the [3H]mepyramine binding site represent the histamine H1 receptor? Re-examination of the histamine H1 receptor with quinine. Liu Q, Horio Y, Fujimoto K, Fukui H. J Pharmacol Exp Ther; 1994 Feb 15; 268(2):959-64. PubMed ID: 8114011 [Abstract] [Full Text] [Related]
20. Molecular properties of central and peripheral histamine H1 and H2 receptors. Carman-Krzan M, Lipnik-Stangelj M. Pflugers Arch; 2000 Feb 15; 439(3 Suppl):R131-2. PubMed ID: 10653166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]